About
Nicolas Gillet is a Professor at the Technological Platform Genetics - Genomics within the Namur Research Institute for Life Sciences at Université de Namur. His research focuses on the interplay between host innate immune effectors like APOBEC3 proteins and viral pathogens, including adenoviruses, coronaviruses, and retroviruses.
- Education: Doctor of Science, Université de Liège (2007)
His work spans virology, genomics, immunology, and molecular therapy, with breakthroughs in APOBEC3B’s role in viral genome restriction, CRISPRi-based therapies for myotonic dystrophy, and SARS-CoV-2 neuroinvasion mechanisms. Recent projects investigate CAR T cell efficiency, post-acute sequelae of SARS-CoV-2, and APOBEC3B transcriptional regulation.
Notable trends in his publications include antiviral innate immunity, viral genome editing, therapeutic gene silencing, and viral-host interactions. He has contributed to 48 research outputs, with a high h-index of 25 and over 2,250 citations. Gillet also serves as a supervisor and principal investigator in multiple projects and manages the Genetics - Genomics technological platform.
- Grants/Awards: h-index 25, 2,250 citations, 2 patents referenced
